- Fund Type: Fund of Funds
- Objective: Global Equity
- Asset Class: Equity
- Geographic Focus: Global
Snapshot for DNB Global II (AFUTLAN)
| Year To Date: | +20.41% | 3-Month: | +11.02% | 3-Year: | +9.59% | 52-Week Range: | 326.26 - 426.96 |
|---|---|---|---|---|---|---|---|
| 1-Month: | +3.81% | 1-Year: | +26.56% | 5-Year: | +4.25% | Beta vs NDDUWI: | 0.77 |
Fund Profile & Information for AFUTLAN
DNB Global (II) is an open-end fund established in Norway. The Fund's objective is long-term capital appreciation. The Fund will solely invest in the DnB NOR Global (V), which invests in large companies listed on exchanges in the US, Europe, and Asia. The investments will be well diversified between various companies, industries, and countries.
| Inception Date: | 01-01-1987 | Telephone: | +47-2231-9800 |
|---|---|---|---|
| Managers: | FILIP BOMAN / WIDAR KIRKEBY | ||
| Web Site: | - | ||
Fundamentals for AFUTLAN
| NAV | (on 2013-05-23) 422.49 |
|---|---|
| Assets (M) | (on 2013-05-23) 223.81 |
| Fund Leveraged | N |
| Minimum Investment | 100,000.00 |
| Minimum Subsequent Investment | - |
Dividends for AFUTLAN
No dividends reported
Fees & Expenses for AFUTLAN
| Front Load | - |
|---|---|
| Back Load | - |
| Current Mgmt Fee | 1.50 |
| Redemption Fee | - |
| 12b1 Fee | - |
| Expense Ratio | 1.52 |
Top Fund Holdings for AFUTLAN
Filing Date: 03/27/2013| Name | Position | Value | % of Total |
|---|---|---|---|
| DNB Global V | 1,539,659 | 219,000,535 | 99.738% |
| Total SA | 51 | 14,283 | 0.007% |
| BNP Paribas SA | 47 | 13,953 | 0.006% |
| GDF Suez | 53 | 5,976 | 0.003% |
| Pernod-Ricard SA | 7 | 5,432 | 0.002% |
| Peugeot SA | 119 | 5,076 | 0.002% |
| AXA SA | 48 | 4,792 | 0.002% |
| Vinci SA | 16 | 4,209 | 0.002% |
| Cie de St-Gobain | 19 | 4,042 | 0.002% |
| Sanofi | 6 | 3,553 | 0.002% |
Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
- 1
- 2
- 3
- 4
- 5
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page